Adrenal disease

Feasibility and Safety Clinical Study of a Novel Technique for Simultaneous Bilateral Adrenal Vein Sampling via Right Elbow Venous Access: A Prospective Clinical Study

Endocr PractPublished Prospective feasibility study

Authors' conclusion

The implementation of simultaneous bilateral AVS through the right cubital vein using specialized catheters significantly simplifies the procedure, increases surgical success, and reduces patient trauma. The high success rate, coupled with a low complication incidence, underscores the technique's safety, feasibility, and substantial clinical implications, suggesting broad applicability for improved PA management.

Study context

Population
Patients with primary aldosteronism (PA), enrolled August 2024 to June 2025
Participants
85 patients
Outcome
Success rate of novel simultaneous bilateral AVS
Methodological detailssingle-centre, single-group
  • Single-centre
  • Single-group

Main finding

As reported in the abstract

Success rate of the novel adrenal venous sampling (AVS) method

97.53%

79/81

Observational data: associations, not effects.

Further findings

Dominant aldosterone secretion among successful cases

Dominant aldosterone secretion in successful cases
59.49% (47/79)

Right adrenal central vein anatomical variants

Type I most common
60.81%

Safety

OutcomeValues
Post-procedural adrenal vein hematomaSimultaneous bilateral AVS via right cubital vein 1.18%

Original publication

Feasibility and Safety Clinical Study of a Novel Technique for Simultaneous Bilateral Adrenal Vein Sampling via Right Elbow Venous Access: A Prospective Clinical Study. Endocr Pract. Published 22 October 2025. doi:10.1016/j.eprac.2025.10.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.